Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$478,443
-$429,882 QoQ
Shares Held
6,658
-13.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#804
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $4,377,396 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
63,441 | $2,149,381 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
5,428 | $914,835 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,019 | $552,124 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
6,658 | $478,443 | |
| 5 | HLN |
Haleon plc
|
17,835 | $166,400 | |
| 6 | EVO |
Evotec SE
|
25,379 | $71,061 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
10,854 | $45,152 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $478,443 | 6,658 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $908,325 | 7,684 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,110,647 | 24,723 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,488,951 | 30,679 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,051,220 | 32,390 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,314,078 | 32,275 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,260,520 | 32,287 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,737,529 | 29,366 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,073,553 | 29,266 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,892,537 | 28,914 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,559,123 | 28,166 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,073,082 | 29,159 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,239,833 | 30,427 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,280,808 | 31,728 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,348,138 | 29,670 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,435,650 | 29,912 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,742,445 | 27,590 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,070,056 | 16,279 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,776,085 | 11,376 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,931,125 | 15,098 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $2,891,748 | 15,517 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $2,392,593 | 15,193 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $2,283,403 | 13,797 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $5,309,699 | 32,108 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $4,368,424 | 31,877 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $2,578,587 | 21,910 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||